Antibacterial effects of Tungsten nanoparticles on the Escherichia coli strains isolated from catheterized urinary tract infection (UTI) cases and Staphylococcus aureus

New Microbiologica

Volumn 33, Issue 4, 2010, Pages 329-335

  Syed, Muhammad Ali ^a   Manzoor, Umair ^b   Shah, Ismat ^c   Bukhari, Habib Ali ^a  

^a Department of Biosciences   (Pakistan)

^b Department of Electrical Computer Engineering   (Pakistan)

^c UNIVERSITY OF DELAWARE   (United States)

Author keywords

Antimicrobial; Catheters; Nanoparticles; Urology urological engineering

Indexed keywords

DISINFECTANT AGENT; METAL NANOPARTICLE; TUNGSTEN;

ARTICLE; BLADDER CATHETERIZATION; CHEMISTRY; DRUG EFFECT; ESCHERICHIA COLI; HUMAN; INDWELLING CATHETER; MICROBIOLOGY; MULTIDRUG RESISTANCE; STAPHYLOCOCCUS AUREUS; URINARY TRACT INFECTION;

CATHETERS, INDWELLING; DISINFECTANTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; HUMANS; METAL NANOPARTICLES; STAPHYLOCOCCUS AUREUS; TUNGSTEN; URINARY CATHETERIZATION; URINARY TRACT INFECTIONS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; STAPHYLOCOCCUS AUREUS;

EID: 78650246212     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. BAQUERO F., NEGRI M. C., MOROSINI M. I., BLAZQUEZ J. (1998). Antibiotics elective environments. Clin. Inf. Dis. 27, 5-11.
2. BECHERT T., BOSWALD M., LUGAUER S., REGENFUS A., GREIL J., GUGGENBICHLER J.P. (1999). The Erlanger silver catheter: in vitro results for antimicrobial activity. Infection. 27 (Suppl 1), 24-29.
3. BECHERT T., STEINRUCKE P., GUGGENBICHLER J.P. (2000). A new method for screening anti-infective biomaterials. Nat. Med. 6, 1053-1056.
4. BLANCHEMAIN N., HAULON S., MARTEL B., TRAISNEL M., MORCELLET M., HILDEBRAND H.F. (2005). Vascular PET prostheses surface modification with cyclodextrin coating: development of a new drug delivery system. Eur. J. Vasc. Endovasc. Surg. 29, 628-632.
5. BRAYNER R., FERRARI-ILIOU R., BRIVOIS N., DJEDIAT S., BENEDETTI M.F., FIÉVET F. (2006). Toxicological impact studies based on Escherichia coli bacteria in ultrafine ZnO nanoparticles colloidal medium. Nano Lett. 6, 866-870.
6. CHO K.H., PARK J.E., OSAKA T., PARK S.G. (2005). The study of antimicrobial activity and preservative effects of nanosilver ingredient. Electrochimica Acta. 51, 956-960. (Pubitemid 41550326)
7. CHOI O, DENG KK, KIM NJ, Ross L JR. SURAMPALLI RY, Hu Z. (2008). The inhibitory effects of silver nanoparticles, silver ions, and silver chloride colloids on microbial growth. Water Res. 42, 3066-3074.
8. DICKINSON G.M., BISNO A.L. (1989). Infections associated with indwelling devices: Infections related to extravascular devices. Antimicrob Agents Chemother. 33, 602-607.
9. FENG Q.L., Wu J.L., CHEN G.Q., CUI FZ., KIM T. N., KIM J.O. (2000). A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J. Biomed. Mater. Res. 52, 662-668.
10. GILBERT P., BROWN M.R.W., COLLIER P.J. (1990). Influence of growth rate on susceptibility to antimicrobial agents; biofilms, cell cycle, dormancy, and stringent response. Antimicrob. Agents Chemother. 34, 1865-1868.
11. ISHIDA H., ISHIDA Y., YUICHI K., OTANI T., SATO K., KOBAYASHI H. (1998). In vitro and in vivo activities of levofloxacin against biofilm producing Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 42, 1641-1645.
12. JONES N., BINATA R, RANJIT K, MANNA AC. (2008). Antibacterial activity of ZnO nanoparticle suspensions on broad spectrum of microorganisms. FEMS Microbiol, lett. 279, 71-76.
13. LEE C., KIM J. Y, LEE W.I., NELSON K.L., YOON J., SEDLAK D.L. (2008). Bactericidal effect of zero-valent iron nanoparticles on Escherichia coli. Environ. Sci. Technol. 42, 4927-4933. (Pubitemid 351956433)
14. LOCKE J.R., HILL D.E., WALZER Y (1985). Incidence of squamous cell carcinoma in patients with longterm catheter drainage. J. Urol. 133, 1034-1035. (Pubitemid 15086789)
15. LOK CN., CHI-MING H.C.M, CHEN R. HE Q.Y, YU WY, SUN H., TAM RK., JEN-FU C.J. F., CHE C.M. (2007). J. Biol. Inorg. Chem. 12, 527.
16. LOK C.N., HO CM., CHEN R., HE QY., YU W Y., SUN, H., TAM, P.K.H., CHIU, J.F, CHE, C.M.J. (2006). Proteomic analysis of the mode of antibacerial action of silver nanoparticles. Proteome Res. 5, 916-924.
17. MANZOOR U., KIM D.K. (2006). Synthesis and enhancement of ultraviolet emission by post-thermal treatment of unique zinc oxide comb-shaped dendritic nanostructures. Scrip. Mater. 54, 807-811.
18. MANZOOR U., KIM D.K. (2009). Size control of ZnO nanostructures formed in different temperature zones by varying Ar flow rate with tunable optical properties. Physica E. 41, 500-505.
19. MOBLEY H.L.T., WARREN J.W. (1987). Urease-positive bacteriuria and obstruction of long-term urinary catheters. J. Clin. Microbiol. 25, 2216-2217.
20. MORONES J.R., ELECHIGUERRA J.L., CAMACHO A., HOLT K., KOURI J.B., RAMIREZ J.T., YACAMAN M.J. (2005). The bactericida effect of silver nanoparticles. Nanotechnology. 16, 2346-53
21. MUDER R., BRENNEN C., WAGENER M.M, ANGELLA M.G. (1992). Bacteremia in a long-term care facility: a five year prospective study of 163 consecutive episodes. Clin. Infect. Did. 14, 647-654.
22. SONDI I., SALOPEK-SONDI B. (2004). Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J. Colloid Interface Sci. 275, 177-182.
23. SPOERING A.M., LEWIS K. (2001). Biofilm and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J. Bacteriol. 183, 6746-6751.
24. STAMM W.E. (1991). Catheter-associated urinary tract infections: epidemiology, pathogenesis and prevention. Am. J. Med. 91, 65S-71S.
25. STOIMENOV P.K., KLINGER R.L., MARCHIN G.L., KLABUNDE K.J. (2002). Metal oxide nanoparticles as bactericidal agents. Langmuir. 18, 6679-6686. (Pubitemid 35383306)
26. SUN R.W, CHEN R., CHUNG N.P., Ho CM., LIN C.L., CHE C.M. (2005). Silver nanoparticles fabricated in Hepes buffer exhibit cytoprotective activities toward HIV-1 infected cells. Chem. Comm. 40, 5059-5061.
27. WARREN J.W., DAMRON D., TENNEY J.H., HOOPES J.M., DEFORGE B., MUNCIE H.L. (1987). Fever, bacteremia, and death as complications of bacteriuria in women with long term urethral catheters. J. Infect. Dis. 155, 1151-1158.
28. WARREN J.W., MUNCIE H.L., HEBEL J.R. (1994). Hall-Craggs Long-term urethral catheterization increases risk of chronic pyelonephritis and renal inflammation. J. Am. Geriatr. Soc. 42, 1286-1290.
29. ZODROW K., BRUNET L., MAHENDRA L., LI D. ZHANG A., LI Q, ALVAREZ P.J.J. (2009). Polysulfone ultrafiltration membranes impregnated with silver nanoparticles show improved biofouling resistance and virus removal. Water Res. 43, 715-723.